• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 20-F/A filed by Zhibao Technology Inc.

    4/28/25 6:16:37 AM ET
    $ZBAO
    Specialty Insurers
    Finance
    Get the next $ZBAO alert in real time by email

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 20-F/A

    (Amendment No.1)

     

    (Mark One)

    ☐ STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    OR

     

    ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the fiscal year ended June 30, 2024

     

    OR

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    OR

     

    ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of event requiring this shell company report

     

    For the transition period from to

     

    Commission File Number: 001-42000

     

    ZHIBAO TECHNOLOGY INC.

    (Exact name of Registrant as specified in its charter)

     

    N/A

    (Translation of Registrant’s name into English)

     

    Cayman Islands

    (Jurisdiction of incorporation or organization)

     

    Floor 3, Building 6, Wuxing Road, Lane 727

    Pudong New Area, Shanghai, China, 201204

    +86 (21) -5089-6502

    (Address of principal executive offices)

     

    Botao Ma

    Chief Executive Officer

    Floor 3, Building 6, Wuxing Road, Lane 727

    Pudong New Area, Shanghai, China, 201204

    Phone: +86 (21) -5089-6502

    Email: [email protected]

    (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

     

    Securities registered or to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol   Name of each exchange on which registered
    Class A Ordinary shares, no par value   ZBAO   Nasdaq Capital Market

     

    Securities registered or to be registered pursuant to Section 12(g) of the Act:

    None

     

    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

    None

     

    Indicate the number of outstanding shares of each of the issuer’s classes of capital stock or common stock as of the close of business covered by the annual report.

     

    14,707,073 Class A ordinary shares and 16,816,692 Class B ordinary shares were issued and outstanding as of June 30, 2024.

     

     

     

     

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

     

    ☐ Yes ☒ No

     

    If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

     

    ☐ Yes ☒ No

     

    Note - Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.

     

    Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

     

    ☒ Yes ☐ No

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

     

    ☒ Yes ☐ No

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “accelerated filer and large accelerated filer” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   Accelerated file   Non-accelerated filer   Emerging growth company
    ☐   ☐   ☒   ☒

     

    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

     

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

     

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

     

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

     

    Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

     

    U.S. GAAP   International Financial Reporting Standards as issued by the International Accounting Standards Board   Other
    ☒   ☐   ☐

     

    If “other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

     

    ☐ Item 17 ☐ Item 18

     

    If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2of the Exchange Act).

     

    ☐ Yes ☒ No

     

    (APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

     

    Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

     

    ☐ Yes ☐ No

     

     

     

     

     

     

    Explanatory Note

     

    Zhibao Technology Inc. (the “Company”, “we”, “our”, or “us”) is filing this Amendment No. 1 to its Annual Report on Form 20-F/A (the “Amendment”) to amend its Annual Report on Form 20-F for the fiscal year ended June 30, 2024 (the “Original Report”), as filed with the United States Securities and Exchange Commission (“SEC”) on October 31, 2024 (“Original Filing Date”), to (i) add a risk factor titled “We previously misstated that our disclosure controls and procedures were effective as of June 30, 2024, when in fact they were not, which could adversely affect investor confidence and expose us to regulatory or legal risks” in “Part I Item 3. Key Information – D. Risk Factors – Risks Related to Our Business and Industry”; and (ii) revise the disclosures regarding the evaluation of the effectiveness of our disclosure controls and procedures in “Part II Item 15. Controls and Procedures.”

     

    As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the certifications required by Rule 13a-14(a) under the Exchange Act are also being filed as exhibits to this Amendment.

     

    Except as described above, no other information included in the Original Report is being amended or updated by this Amendment and, other than as described herein, this Amendment does not purport to reflect any information or events subsequent to the Original Report. This Amendment should be read in conjunction with the Original Filing, which continues to speak as of the date of the Original Filing Date, except as expressly contained herein, we have not updated, modified or supplemented the disclosures contained in the Original Report.

     

     

     

     

    Table of Contents

     

        Page 
    PART I    
    ITEM 3. KEY INFORMATION 1
         

    PART II

       
    ITEM 15. CONTROLS AND PROCEDURES 2

     

    i

     

     

    ITEM 3. KEY INFORMATION

     

    D. Risk Factors.

     

    Risks Related to Our Business and Industry

     

    We previously misstated that our disclosure controls and procedures were effective as of June 30, 2024, when in fact they were not, which could adversely affect investor confidence and expose us to regulatory or legal risks.

     

    In our Original Report on Form 20-F for the fiscal year ended June 30, 2024, we incorrectly stated that our disclosure controls and procedures were effective as of that date. We have subsequently determined that our disclosure controls and procedures were, in fact, ineffective as of June 30, 2024, due to our material weaknesses in our internal control over financial reporting described below.

     

    As of June 30, 2024, we identified the material weaknesses related to: (i) insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP commensurate with its financial reporting requirements, and (ii) the Company has inadequate proper IT control related logical access security.

     

    This misstatement may undermine investor confidence in the accuracy and reliability of our public disclosures and the effectiveness of our internal controls and procedures. Additionally, inaccurate disclosure regarding the effectiveness of our disclosure controls and procedures may subject us to increased scrutiny by the SEC, potential liability under the Exchange Act, including Sections 13(a) and 15(d) thereof, and under the anti-fraud provisions of the Securities Act of 1933, as amended.

     

    Such exposure may result in regulatory investigations, enforcement actions, civil litigation, and reputational harm. If we fail to remediate the identified deficiencies and to maintain effective disclosure controls and procedures in the future, our ability to comply with our reporting obligations under the Exchange Act and to provide accurate and timely disclosure to investors could be impaired. Any such failure could adversely affect our business, financial condition, results of operations, and the market price of our securities.

     

    1

     

     

    ITEM 15. CONTROLS AND PROCEDURES  

     

    Disclosure Controls and Procedures

     

    Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we carried out an evaluation of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) under the Exchange Act as of the end of the period covered by this report, as required by Rule 13a-15(b) under the Exchange Act.

     

    Based upon this evaluation, our management, with the participation of our chief executive officer and chief financial officer, has concluded that, as of June 30, 2024, our disclosure controls and procedures were ineffective due to the material weaknesses in internal control over financial reporting identified below.

     

    Disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in SEC’s rule and forms and that such information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

     

    Management’s Annual Report on Internal Control over Financial Reporting

     

    Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the U.S. Exchange Act. As required by Rule 13a-15(c) of the U.S. Exchange Act.

     

    Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that receipts and expenditures of our company are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of the unauthorized acquisition, use or disposition of our company’s assets that could have a material effect on the consolidated financial statements.

     

    Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of our internal control over financial reporting to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

     

    As required by Rule 13a-15(c) of the Exchange Act, our management conducted an evaluation of our company’s internal control over financial reporting as of June 30, 2024 based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management concluded that our internal control over financial reporting was ineffective as of June 30, 2024.

     

    2

     

     

    In the course of preparing our consolidated financial statements in the prior years, we identified two material weaknesses which have not been remedied in our internal control over financial reporting, as defined in the standards established by the Public Company Accounting Oversight Board of the United States. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

     

    As of June 30, 2024, we identified the material weaknesses related to: (i) insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP commensurate with its financial reporting requirements, and (ii) the Company has inadequate proper IT control related logical access security.

     

    Our management is currently in the process of evaluating the steps necessary to remediate the ineffectiveness, including: (i) implementing regular and continuous U.S. GAAP accounting and financial reporting training programs for its accounting and financial reporting personnel; (ii) implement formal access and change controls to our systems, and make changes to our information technology systems; and (iii) establish more robust processes supporting internal control over financial reporting.

     

    As a company with less than US$1.235 billion in revenue for our last fiscal year, we qualify as an “emerging growth company” pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company’s internal control over financial reporting.

     

    Changes in Internal Control over Financial Reporting

     

    Other than those disclosed above, there were no changes in our internal controls over financial reporting during our fiscal year ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

     

    ITEM 19. EXHIBITS

     

    Exhibit
    Number
      Description of Document
    12.1*   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act
    12.2*   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act
    13.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    13.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    101. INS***   Inline XBRL Instance Document.
    101. SCH***   Inline XBRL Taxonomy Extension Schema Document.
    101. CAL***   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
    101. DEF***   Inline XBRL Taxonomy Extension Definition Linkbase Document.
    101. LAB***   Inline XBRL Taxonomy Extension Label Linkbase Document.
    101. PRE***   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
    104***   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    *Filed herewith
    **Furnished herewith
    ***Previously filed with the Original Filing

     

    3

     

     

    SIGNATURES

     

    The registrant hereby certifies that it meets all of the requirements for filing its annual report on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

     

      Zhibao Technology Inc.
         
      By: /s/ Botao Ma
      Name:  Botao Ma
      Title: Chief Executive Officer

     

    Date: April 28, 2025

     

     

    4

    0001966750 true FY 0001966750 2023-07-01 2024-06-30 0001966750 dei:BusinessContactMember 2023-07-01 2024-06-30 0001966750 us-gaap:CommonClassAMember 2024-06-30 0001966750 us-gaap:CommonClassBMember 2024-06-30 xbrli:shares
    Get the next $ZBAO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZBAO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZBAO
    SEC Filings

    View All

    SEC Form EFFECT filed by Zhibao Technology Inc.

    EFFECT - Zhibao Technology Inc. (0001966750) (Filer)

    2/9/26 12:15:15 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    SEC Form POS AM filed by Zhibao Technology Inc.

    POS AM - Zhibao Technology Inc. (0001966750) (Filer)

    2/6/26 7:10:25 PM ET
    $ZBAO
    Specialty Insurers
    Finance

    Amendment: SEC Form F-1/A filed by Zhibao Technology Inc.

    F-1/A - Zhibao Technology Inc. (0001966750) (Filer)

    1/22/26 5:08:34 PM ET
    $ZBAO
    Specialty Insurers
    Finance

    $ZBAO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Zhibao Technology Announces Regaining Compliance with Nasdaq Listing Rules

    Shanghai, China--(Newsfile Corp. - January 16, 2026) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," or the "Company"), a leading high-growth InsurTech company providing digital insurance brokerage services in China, today announced that it received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on January 12, 2026. The Compliance Notice confirms that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires the timely filing of periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC").As previously announced on November 21, 2025, Na

    1/16/26 8:30:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    Zhibao Technology Inc. Reports Fiscal Year 2025 Financial Results

    Shanghai, China--(Newsfile Corp. - January 13, 2026) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced its fiscal year 2025 financial results for the twelve month period ended June 30, 2025.Recent DevelopmentsProduct Offerings and Collaborations The Company's subsidiary, Zhibao Labuan Reinsurance Company Limited ("Zhibao Labuan") received its general reinsurance license in July 2025 from its regulator, Labuan Financial Services Authority ("LFSA"). Additionally, Zhibao Labuan was assigned a Financial

    1/13/26 8:59:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    Zhibao Technology Inc. Launches Zhibao Yingshi - A Joint Venture to Accelerate Development of Medical Insurance Products

    Shanghai, China--(Newsfile Corp. - December 12, 2025) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the commencement of operations of Shanghai Zhibao Yingshi Health Technology Co. Ltd ("Zhibao Yingshi"), a joint venture company that was formed in September 2025 by Zhibao and Shanghai Xingtao Network Technology Co. Ltd, ("Yingshi Health"), a player in the mid-end medical insurance space in China. In November 2025, the Company recorded the first revenue in Zhibao Yingshi, primarily from service fee

    12/12/25 9:00:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    $ZBAO
    Leadership Updates

    Live Leadership Updates

    View All

    Zhibao Technology Inc. Announces the Appointment of New Executives

    Shanghai, China--(Newsfile Corp. - December 5, 2025) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao" or the "Company"), a leading and high-growth InsurTech company providing digital insurance brokerage services in China, today announced the appointment of three new Executives. Effective December 1, 2025, Mr. Xiaowei Le as the Company's new Chief Operating Officer, Mr. Xiao Luo as the Company's new Chief Marketing Officer, and Mr. Guangtong Ren as the Company's new Chief Actuary. All three executives previously held roles Zhibao's Chinese operating entities ("Zhibao China"). The appointment of these executives reflect their exceptional contributions to the strong performance and growth of Zh

    12/5/25 9:00:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    Zhibao Technology Inc. Appoints Xiaowei Le as Chief Growth Officer

    Shanghai, China--(Newsfile Corp. - June 27, 2024) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao" or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the appointment of Xiaowei Le as its Chief Growth Officer, effective immediately.Xiaowei LeTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10601/214595_86e63a1df41708ab_002full.jpgWith an illustrious career with more than 25 years' experience in the insurance industry, Mr. Le brings a wealth of expertise to Zhibao as it enters a new phase of growth, expansion an

    6/27/24 5:30:00 PM ET
    $ZBAO
    Specialty Insurers
    Finance

    $ZBAO
    Financials

    Live finance-specific insights

    View All

    Zhibao Technology Announces Regaining Compliance with Nasdaq Listing Rules

    Shanghai, China--(Newsfile Corp. - January 16, 2026) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," or the "Company"), a leading high-growth InsurTech company providing digital insurance brokerage services in China, today announced that it received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on January 12, 2026. The Compliance Notice confirms that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires the timely filing of periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC").As previously announced on November 21, 2025, Na

    1/16/26 8:30:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    Zhibao Technology Inc. Reports Fiscal Year 2025 Financial Results

    Shanghai, China--(Newsfile Corp. - January 13, 2026) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced its fiscal year 2025 financial results for the twelve month period ended June 30, 2025.Recent DevelopmentsProduct Offerings and Collaborations The Company's subsidiary, Zhibao Labuan Reinsurance Company Limited ("Zhibao Labuan") received its general reinsurance license in July 2025 from its regulator, Labuan Financial Services Authority ("LFSA"). Additionally, Zhibao Labuan was assigned a Financial

    1/13/26 8:59:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance

    Zhibao Technology Inc. Launches Zhibao Yingshi - A Joint Venture to Accelerate Development of Medical Insurance Products

    Shanghai, China--(Newsfile Corp. - December 12, 2025) - Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the commencement of operations of Shanghai Zhibao Yingshi Health Technology Co. Ltd ("Zhibao Yingshi"), a joint venture company that was formed in September 2025 by Zhibao and Shanghai Xingtao Network Technology Co. Ltd, ("Yingshi Health"), a player in the mid-end medical insurance space in China. In November 2025, the Company recorded the first revenue in Zhibao Yingshi, primarily from service fee

    12/12/25 9:00:00 AM ET
    $ZBAO
    Specialty Insurers
    Finance